Aperio ePathology

Implementation from a Practical Perspective – Part II

Leica Puneet

Digital pathology is the practice of converting microscopic glass slides into images that can be viewed, managed and analyzed. Part I of this series focused on the benefits that Aperio ePathology provides patients, practitioners, and payers. Puneet Sarin, vice president, Pathology Imaging Business at Leica Biosystems, now examines the value of implementing digital pathology, the inherent challenges and success factors for CIOs, and the mainstream adoption of digital pathology.

Q: Tell us about Leica Biosystems and what sets Aperio ePathology Solutions apart from other Digital Pathology technology that is on the market today?

What differentiates Leica Biosystems Aperio ePathology from other digital pathology technology is the 15 years of market leadership and experience that we bring to the healthcare and life sciences industries. We have over 1,600 digital pathology systems worldwide. That means there are more Aperio installed Digital Pathology systems out there than all others combined. With more installations, we are the recognized leader in this space—not just because of our proven technology but because of our experience in successfully deploying largescale Digital Pathology implementations.

Also, anytime I think about what sets our company apart, I like to start with Leica Biosystems mission. Our mission is to advance cancer diagnostics, improving lives. At the core of everything we realize that, behind every glass slide, there are patients and families. That’s what brings us together. Improving people’s lives is our ultimate, overarching purpose and we know that this is our customer’s mission as well.

Leica Biosystems is the only company to enable our customers to engage in pathology workflow from biopsy all the way to diagnosis. IT solutions are the thread that will tie all of the component parts together.

Q: How can CIOs effectively implement Aperio digital pathology solutions in the hospital?

It starts with having the buy-in and support of the hospital’s Pathologists. It is also important for CIOs to have the right vendor partner, someone who has the track record and experience of implementing Digital Pathology.

Aperio has successfully completed hundreds of complex implementations for Digital Pathology. We understand the special requirements for handling digitized glass slides in Pathology and the need for sharing them securely between multiple locations within or outside the institution’s firewalls. We have the expertise to deliver such capability with speed and security, as well as within different IT environments for our customers.

Our successful implementation of Digital Pathology systems, including many large-scale global installations, highlight the company’s proven implementation methodologies and our team’s experience. Our commitment, as a company, to “open” architecture and standard file formats ensures maximum interoperability with different Lab Information Systems (LIS) and other IT systems in the broader healthcare enterprise.

At Leica Biosystems, we have specifically developed the tools and capabilities required to meet the needs of technical and professional workflow components. For example, we have advanced sample management and workflow reporting capabilities with Leica Biosystems CEREBRO product and we have built smart software applications that provide device level information, dashboards, and inventory management to lab personnel at their fingertips.

Q: What is the future for Aperio ePathology?

The future is very bright with more and more institutions looking towards Digital Pathology as a way to improve turnaround times, provide better outcomes, and increase patient satisfaction. We are continuing to invest in our technology solutions. We are bringing the notion of the digital cockpit for Pathologists— with the aim of facilitating workflow efficiency, information sharing and ultimately better clinical decision making.

Advances in digital pathology are helping to revolutionize patient care; improving efficiency, transparency, and consistency in decision making and treatment. Whether it’s a scanning experience, unparalleled viewing, or world-class implementation with the integration of IT or LIS systems, including training and technical support, we want to be there for our customers.

At Leica Biosystems, we believe that innovation defines our future. By combining Aperio Digital Pathology with other Leica Biosystems solutions, we clearly see ourselves as the complete workflow company. We have hardware and software from the time the tissue is acquired to the point the report is generated in the system. This capability truly allows us to move forward in our mission: advancing cancer diagnostics, improving lives.

This post is sponsored by Leica Biosystems.
For more information about Aperio ePathology Solutions, go to LeicaBiosystems.com/Insight.